Research any stock – with downloadable financial data. Plus market metrics.
View and download data on stock financials, prices, valuations, ownership and much more.
A powerful tool to help you filter stocks using the right metrics and data.
Metrics that we have set to give you readymade shortlists. A great base to start on which you can build further.
Sugar stocks have been fired up lately on expectations that the industry is set to turn a corner. While the sector has seen many false dawns on reform hopes in the past, the changes we are seeing this time around could turn out to be the real deal.
Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?
There are certain characteristics which make evaluating banking and finance stocks different from others which produce goods and services. Money cannot be lent to someone unless there is an inflow by way of capital or debt. Since it is not practical to lend only from capital, borrowing (or leverage) is the sustaining food for this business. Naturally in using this leverage, there are good and bad apples.
Our Stock research philosophy
With it comes to doing stock research, quality, growth and right price for the business – all matter to us. We also believe that good businesses can spring up in any market cap segment. Therefore, we don’t have defined allocations to large-caps, mid-caps, and small-caps or defined allocations to sectors in our stock recommendations. Here’s how we build Prime Stocks.
- To start with, we consider the entire Nifty 500 basket – given that this covers almost the entire listed market cap, it throws up all available opportunities.
- To this, we apply basic filters to remove the very illiquid stocks so that you’re actually able to invest the amounts you wish to. Our liquidity filter applies regardless of the stock’s market cap.
- Then, we do a further round of elimination to weed out those with very shaky fundamentals – such as the severely loss-making, negative net worth, heavily indebted, and more.
- On this universe, out stock research methodology applies quantitative filters to rank this universe of stocks. This helps set a basic bar on the fundamental metrics that a company needs, to make it to our shortlist.
- Our model considers over 20 different metrics to measure quality and growth alone, besides a series of other metrics to understand stock risks, volatility, and valuations.
- The stock research methodology we have developed measures balance sheet strength, growth in revenue and profitability, as well as the quality of this growth. We combine both short-term and long-term averages to ensure that we’re not overtly influenced by the latest numbers. For example, while we look at revenue or earnings growth, we also look at how strong or stable this growth has been, whether or not it leads to cash flows, whether or not it is real growth. While we look at debt levels, we also look at ability to service interest and whether the debt has been put to good use. While we look at NPAs, we also see what the loan book is like and trends in NPAs.
Stock research deep dive
From the shortlist our model generates, we dig deeper to understand more about each company, its sector, its growth and profit drivers, valuations, and more. This exercise is an entirely qualitative analysis. This quantitative-qualitative blend gives us the ability to assess stocks and opportunities across sectors and market caps. It also removes any potential bias we may have towards particular sectors. It helps us offer a mix of styles. Our ‘buy’ list can and often will feature growth-style stocks, quality stocks, value or contrarian picks, or even dividend plays.
We additionally have a ‘Watchlist’, where we list stocks that we think hold promise, but are not ‘buys’ because we are watching developments. These could be related to valuations or the business. So, not all ‘Watchlist’ stocks will move to ‘Buys’! We also give you alerts on when a stock is overvalued or where the fundamental thesis fails or changes. We issue a ‘Sell’ call at such times.
Stock research doesn’t have to be the domain of only the market savvy. Subscribe to PrimeInvestor and use our recommendations, screeners and rankings to be a top stock research analyst yourself!